Meta-analysis of multiple microarray datasets reveals a common gene signature of metastasis in solid tumors

BMC Medical Genomics

Volumn 4, Issue , 2011, Pages

  Daves, Marla H ^a   Hilsenbeck, Susan G ^a   Lau, Ching C ^a   Man, Tsz Kwong ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; INTEGRIN; TUMOR MARKER; VASCULOTROPIN; VASCULOTROPIN A;

ARTICLE; CANCER GENETICS; CLINICAL FEATURE; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE MUTATION; GENETIC DATABASE; HUMAN; METASTASIS; MICROARRAY ANALYSIS; PRIMARY TUMOR; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SOLID TUMOR; TUMOR GENE; DISEASE COURSE; DNA MICROARRAY; FACTUAL DATABASE; GENE EXPRESSION PROFILING; GENETICS; META ANALYSIS;

DATABASES, FACTUAL; DISEASE PROGRESSION; GENE EXPRESSION PROFILING; HUMANS; NEOPLASM METASTASIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 79959976479     PISSN: None     EISSN: 17558794     Source Type: Journal    
DOI: 10.1186/1755-8794-4-56     Document Type: Article

References (58)

1. Cancer metastasis as a therapeutic target. Sleeman J, Steeg PS, Eur J Cancer 46 1177 1180
2. The war on cancer: a review. Sporn MB, Ann N Y Acad Sci 1997 833 137 146 10.1111/j.1749-6632.1997.tb48599.x 9616746 (Pubitemid 28045246)
3. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Fidler IJ, Nat Rev Cancer 2003 3 453 458 10.1038/nrc1098 12778135 (Pubitemid 37328849)
4. Metastasis suppressor pathways - an evolving paradigm. Shevde LA, Welch DR, Cancer Lett 2003 198 1 20 10.1016/S0304-3835(03)00304-5 12893425 (Pubitemid 37289098)
5. A molecular signature of metastasis in primary solid tumors. Ramaswamy S, Ross KN, Lander ES, Golub TR, Nat Genet 2003 33 49 54 10.1038/ng1060 12469122 (Pubitemid 36068681)
6. A comparison of meta-analysis methods for detecting differentially expressed genes in microarray experiments. Hong F, Breitling R, Bioinformatics 2008 24 374 382 10.1093/bioinformatics/btm620 18204063 (Pubitemid 351189013)
7. Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression. Rhodes DR, Yu J, Shanker K, Deshpande N, Varambally R, Ghosh D, Barrette T, Pandey A, Chinnaiyan AM, Proc Natl Acad Sci USA 2004 101 9309 9314 10.1073/pnas.0401994101 15184677 (Pubitemid 38812872)
8. A cross-study comparison of gene expression studies for the molecular classification of lung cancer. Parmigiani G, Garrett-Mayer ES, Anbazhagan R, Gabrielson E, Clin Cancer Res 2004 10 2922 2927 10.1158/1078-0432.CCR-03-0490 15131026 (Pubitemid 38619666)
9. Oncomine 4.3 Research Edition. http://www.oncomine.org
10. ONCOMINE: a cancer microarray database and integrated data-mining platform. Rhodes DR, Yu J, Shanker K, Deshpande N, Varambally R, Ghosh D, Barrette T, Pandey A, Chinnaiyan AM, Neoplasia 2004 6 1 6 15068665 (Pubitemid 38391943)
11. Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles. Rhodes DR, Kalyana-Sundaram S, Mahavisno V, Varambally R, Yu J, Briggs BB, Barrette TR, Anstet MJ, Kincead-Beal C, Kulkarni P, Varambally S, Ghosh D, Chinnaiyan AM, Neoplasia 2007 9 166 180 10.1593/neo.07112 17356713
12. Predicting biomarkers for ovarian cancer using gene-expression microarrays. Adib TR, Henderson S, Perrett C, Hewitt D, Bourmpoulia D, Ledermann J, Boshoff C, Br J Cancer 2004 90 686 692 10.1038/sj.bjc.6601603 14760385 (Pubitemid 38297211)
13. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Bhattacharjee A, Richards WG, Staunton J, Li C, Monti S, Vasa P, Ladd C, Beheshti J, Bueno R, Gillette M, Loda M, Weber G, Mark EJ, Lander ES, Wong W, Johnson BE, Golub TR, Sugarbaker DJ, Meyerson M, Proc Natl Acad Sci USA 2001 98 13790 13795 10.1073/pnas.191502998 11707567 (Pubitemid 33115977)
14. International Genomics Consortium Expression Project for Oncology. http://www.intgen.org/expo/publicly-available-data/
15. Variation in gene expression patterns in human gastric cancers. Chen X, Leung SY, Yuen ST, Chu KM, Ji J, Li R, Chan AS, Law S, Troyanskaya OG, Wong J, So S, Botstein D, Brown PO, Mol Biol Cell 2003 14 3208 3215 10.1091/mbc.E02-12- 0833 12925757 (Pubitemid 37013121)
16. Diversity of gene expression in adenocarcinoma of the lung. Garber ME, Troyanskaya OG, Schluens K, Petersen S, Thaesler Z, Pacyna-Gengelbach M, van de Rijn M, Rosen GD, Perou CM, Whyte RI, Altman RB, Brown PO, Botstein D, Petersen I, Proc Natl Acad Sci USA 2001 98 13784 13789 10.1073/pnas.241500798 11707590 (Pubitemid 33115976)
17. Deciphering cellular states of innate tumor drug responses. Graudens E, Boulanger V, Mollard C, Mariage-Samson R, Barlet X, Gremy G, Couillault C, Lajemi M, Piatier-Tonneau D, Zaborski P, Eveno E, Auffray C, Imbeaud S, Genome Biol 2006 7 19 10.1186/gb-2006-7-3-r19 16542501 (Pubitemid 43871874)
18. The gene expression signatures of melanoma progression. Haqq C, Nosrati M, Sudilovsky D, Crothers J, Khodabakhsh D, Pulliam BL, Federman S, Miller JR, Allen RE, Singer MI, Leong SP, Ljung BM, Sagebiel RW, Kashani-Sabet M, Proc Natl Acad Sci USA 2005 102 6092 6097 10.1073/pnas.0501564102 15833814 (Pubitemid 40594260)
19. Gene expression analysis of human prostate carcinoma during hormonal therapy identifies androgen-responsive genes and mechanisms of therapy resistance. Holzbeierlein J, Lal P, LaTulippe E, Smith A, Satagopan J, Zhang L, Ryan C, Smith S, Scher H, Scardino P, Reuter V, Gerald WL, Am J Pathol 2004 164 217 227 10.1016/S0002-9440(10)63112-4 14695335 (Pubitemid 38364606)
20. Expression profiles provide insights into early malignant potential and skeletal abnormalities in multiple endocrine neoplasia type 2B syndrome tumors. Jain S, Watson MA, DeBenedetti MK, Hiraki Y, Moley JF, Milbrandt J, Cancer Res 2004 64 3907 3913 10.1158/0008-5472.CAN-03-3801 15173001 (Pubitemid 38697303)
21. Whole genome analysis for liver metastasis gene signatures in colorectal cancer. Ki DH, Jeung HC, Park CH, Kang SH, Lee GY, Lee WS, Kim NK, Chung HC, Rha SY, Int J Cancer 2007 121 2005 2012 10.1002/ijc.22975 17640062 (Pubitemid 47463164)
22. Gene expression profiling identifies clinically relevant subtypes of prostate cancer. Lapointe J, Li C, Higgins JP, van de Rijn M, Bair E, Montgomery K, Ferrari M, Egevad L, Rayford W, Bergerheim U, Ekman P, DeMarzo AM, Tibshirani R, Botstein D, Brown PO, Brooks JD, Pollack JR, Proc Natl Acad Sci USA 2004 101 811 816 10.1073/pnas.0304146101 14711987 (Pubitemid 38121040)
23. Comprehensive gene expression analysis of prostate cancer reveals distinct transcriptional programs associated with metastatic disease. LaTulippe E, Satagopan J, Smith A, Scher H, Scardino P, Reuter V, Gerald WL, Cancer Res 2002 62 4499 4506 12154061 (Pubitemid 34827314)
24. Identification of SOX4 target genes using phylogenetic footprinting-based prediction from expression microarrays suggests that overexpression of SOX4 potentiates metastasis in hepatocellular carcinoma. Liao YL, Sun YM, Chau GY, Chau YP, Lai TC, Wang JL, Horng JT, Hsiao M, Tsou AP, Oncogene 2008 27 5578 5589 10.1038/onc.2008.168 18504433
25. Gene expression patterns and gene copy number changes in dermatofibrosarcoma protuberans. Linn SC, West RB, Pollack JR, Zhu S, Hernandez-Boussard T, Nielsen TO, Rubin BP, Patel R, Goldblum JR, Siegmund D, Botstein D, Brown PO, Gilks CB, van de Rijn M, Am J Pathol 2003 163 2383 2395 10.1016/S0002-9440(10)63593-6 14633610 (Pubitemid 37466479)
26. Expression profiling reveals hepsin overexpression in prostate cancer. Magee JA, Araki T, Patil S, Ehrig T, True L, Humphrey PA, Catalona WJ, Watson MA, Milbrandt J, Cancer Res 2001 61 5692 5696 11479199 (Pubitemid 32769078)
27. Gene expression analysis of soft tissue sarcomas: characterization and reclassification of malignant fibrous histiocytoma. Nakayama R, Nemoto T, Takahashi H, Ohta T, Kawai A, Seki K, Yoshida T, Toyama Y, Ichikawa H, Hasegawa T, Mod Pathol 2007 20 749 759 10.1038/modpathol.3800794 17464315 (Pubitemid 46933446)
28. Molecular characterisation of soft tissue tumours: a gene expression study. Nielsen TO, West RB, Linn SC, Alter O, Knowling MA, O'Connell JX, Zhu S, Fero M, Sherlock G, Pollack JR, Brown PO, Botstein D, van de Rijn M, Lancet 2002 359 1301 1307 10.1016/S0140-6736(02)08270-3 11965276 (Pubitemid 34310636)
29. Prediction of high risk Ewing's sarcoma by gene expression profiling. Ohali A, Avigad S, Zaizov R, Ophir R, Horn-Saban S, Cohen IJ, Meller I, Kollender Y, Issakov J, Yaniv I, Oncogene 2004 23 8997 9006 10.1038/sj.onc. 1208060 15467746 (Pubitemid 39657791)
30. Gene expression signature predicts lymphatic metastasis in squamous cell carcinoma of the oral cavity. O'Donnell RK, Kupferman M, Wei SJ, Singhal S, Weber R, O'Malley B, Cheng Y, Putt M, Feldman M, Ziober B, Muschel RJ, Oncogene 2005 24 1244 1251 10.1038/sj.onc.1208285 15558013 (Pubitemid 40313925)
31. The gene associated with trichorhinophalangeal syndrome in humans is overexpressed in breast cancer. Radvanyi L, Singh-Sandhu D, Gallichan S, Lovitt C, Pedyczak A, Mallo G, Gish K, Kwok K, Hanna W, Zubovits J, Armes J, Venter D, Hakimi J, Shortreed J, Donovan M, Parrington M, Dunn P, Oomen R, Tartaglia J, Berinstein NL, Proc Natl Acad Sci USA 2005 102 11005 11010 10.1073/pnas. 0500904102 16043716 (Pubitemid 41105983)
32. Multiclass cancer diagnosis using tumor gene expression signatures. Ramaswamy S, Tamayo P, Rifkin R, Mukherjee S, Yeang CH, Angelo M, Ladd C, Reich M, Latulippe E, Mesirov JP, Poggio T, Gerald W, Loda M, Lander ES, Golub TR, Proc Natl Acad Sci USA 2001 98 15149 15154 10.1073/pnas.211566398 11742071 (Pubitemid 34013984)
33. The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis. Riker AI, Enkemann SA, Fodstad O, Liu S, Ren S, Morris C, Xi Y, Howell P, Metge B, Samant RS, Shevde LA, Li W, Eschrich S, Daud A, Ju J, Matta J, BMC Med Genomics 2008 1 13 10.1186/1755-8794-1-13 18442402
34. Classification of clear-cell sarcoma as a subtype of melanoma by genomic profiling. Segal NH, Pavlidis P, Noble WS, Antonescu CR, Viale A, Wesley UV, Busam K, Gallardo H, DeSantis D, Brennan MF, Cordon-Cardo C, Wolchok JD, Houghton AN, J Clin Oncol 2003 21 1775 1781 10.1200/JCO.2003.10.108 12721254 (Pubitemid 46638591)
35. Classification and subtype prediction of adult soft tissue sarcoma by functional genomics. Segal NH, Pavlidis P, Antonescu CR, Maki RG, Noble WS, DeSantis D, Woodruff JM, Lewis JJ, Brennan MF, Houghton AN, Cordon-Cardo C, Am J Pathol 2003 163 691 700 10.1016/S0002-9440(10)63696-6 12875988 (Pubitemid 36909430)
36. Repeated observation of breast tumor subtypes in independent gene expression data sets. Sorlie T, Tibshirani R, Parker J, Hastie T, Marron JS, Nobel A, Deng S, Johnsen H, Pesich R, Geisler S, Demeter J, Perou CM, Lonning PE, Brown PO, Borresen-Dale AL, Botstein D, Proc Natl Acad Sci USA 2003 100 8418 8423 10.1073/pnas.0932692100 12829800 (Pubitemid 36842560)
37. Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome. Tothill RW, Tinker AV, George J, Brown R, Fox SB, Lade S, Johnson DS, Trivett MK, Etemadmoghadam D, Locandro B, Traficante N, Fereday S, Hung JA, Chiew YE, Haviv I, Gertig D, DeFazio A, Bowtell DD, Clin Cancer Res 2008 14 5198 5208 10.1158/1078-0432.CCR-08-0196 18698038
38. Transcriptional silencing of zinc finger protein 185 identified by expression profiling is associated with prostate cancer progression. Vanaja DK, Cheville JC, Iturria SJ, Young CY, Cancer Res 2003 63 3877 3882 12873976 (Pubitemid 36917897)
39. Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression. Varambally S, Yu J, Laxman B, Rhodes DR, Mehra R, Tomlins SA, Shah RB, Chandran U, Monzon FA, Becich MJ, Wei JT, Pienta KJ, Ghosh D, Rubin MA, Chinnaiyan AM, Cancer Cell 2005 8 393 406 10.1016/j.ccr.2005.10.001 16286247 (Pubitemid 41579834)
40. Gene expression profiles of primary breast tumors maintained in distant metastases. Weigelt B, Glas AM, Wessels LF, Witteveen AT, Peterse JL, van't Veer LJ, Proc Natl Acad Sci USA 2003 100 15901 15905 10.1073/pnas.2634067100 14665696 (Pubitemid 38021087)
41. Gene expression changes in an animal melanoma model correlate with aggressiveness of human melanoma metastases. Xu L, Shen SS, Hoshida Y, Subramanian A, Ross K, Brunet JP, Wagner SN, Ramaswamy S, Mesirov JP, Hynes RO, Mol Cancer Res 2008 6 760 769 10.1158/1541-7786.MCR-07-0344 18505921
42. Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning. Ye QH, Qin LX, Forgues M, He P, Kim JW, Peng AC, Simon R, Li Y, Robles AI, Chen Y, Ma ZC, Wu ZQ, Ye SL, Liu YK, Tang ZY, Wang XW, Nat Med 2003 9 416 423 10.1038/nm843 12640447 (Pubitemid 36460075)
43. Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy. Yu YP, Landsittel D, Jing L, Nelson J, Ren B, Liu L, McDonald C, Thomas R, Dhir R, Finkelstein S, Michalopoulos G, Becich M, Luo JH, J Clin Oncol 2004 22 2790 2799 10.1200/JCO.2004.05.158 15254046 (Pubitemid 41079896)
44. R: A Language and Environment for Statistical Computing. R Development Core Team, Vienna, Austria: R Foundation for Statistical Computing 2010
45. Ingenuity Systems. http://www.ingenuity.com
46. Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. Benjamini Y, Hochberg Y, Journal of the Royal Statistical Society B 1995 57 289 300
47. Analysis of Gene Expression Data Using BRB-Array Tools. Simon R, Lam A, Li MC, Ngan M, Menenzes S, Zhao Y, Cancer Inform 2007 3 11 17 19455231 (Pubitemid 47075796)
48. Gene Set Expression Comparison kit for BRB-ArrayTools. Xu X, Zhao Y, Simon R, Bioinformatics 2008 24 137 139 10.1093/bioinformatics/btm541 18006549
49. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Edgar R, Domrachev M, Lash AE, Nucleic Acids Res 2002 30 207 210 10.1093/nar/30.1.207 11752295 (Pubitemid 34679544)
50. Implementation of GenePattern within the Stanford Microarray Database. Hubble J, Demeter J, Jin H, Mao M, Nitzberg M, Reddy TB, Wymore F, Zachariah ZK, Sherlock G, Ball CA, Nucleic Acids Res 2009 37 898 901 10.1093/nar/gkn786 18953035
51. The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Lamb J, Crawford ED, Peck D, Modell JW, Blat IC, Wrobel MJ, Lerner J, Brunet JP, Subramanian A, Ross KN, Reich M, Hieronymus H, Wei G, Armstrong SA, Haggarty SJ, Clemons PA, Wei R, Carr SA, Lander ES, Golub TR, Science 2006 313 1929 1935 10.1126/science.1132939 17008526 (Pubitemid 44497995)
52. The Connectivity Map: a new tool for biomedical research. Lamb J, Nat Rev Cancer 2007 7 54 60 10.1038/nrc2044 17186018 (Pubitemid 46020847)
53. Cancer therapies utilizing the camptothecins: a review of the in vivo literature. Venditto VJ, Simanek EE, Mol Pharm 7 307 349
54. Small molecule regulators of autophagy identified by an image-based high-throughput screen. Zhang L, Yu J, Pan H, Hu P, Hao Y, Cai W, Zhu H, Yu AD, Xie X, Ma D, Yuan J, Proc Natl Acad Sci USA 2007 104 19023 19028 10.1073/pnas.0709695104 18024584
55. Metastasis signatures: genes regulating tumor-microenvironment interactions predict metastatic behavior. Albini A, Mirisola V, Pfeffer U, Cancer Metastasis Rev 2008 27 75 83 10.1007/s10555-007-9111-x 18046511
56. Metastasis suppressor proteins: discovery, molecular mechanisms, and clinical application. Rinker-Schaeffer CW, O'Keefe JP, Welch DR, Theodorescu D, Clin Cancer Res 2006 12 3882 3889 10.1158/1078-0432.CCR-06-1014 16818682 (Pubitemid 44078070)
57. Combining probability from independent tests: the weighted Z-method is superior to Fisher's approach. Whitlock MC, J Evol Biol 2005 18 1368 1373 10.1111/j.1420-9101.2005.00917.x 16135132 (Pubitemid 41725687)
58. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Moher D, Liberati A, Tetzlaff J, Altman DG, PLoS Med 2009 6 1000097 10.1371/journal.pmed.1000097 19621072